Bedaquiline targets the ε subunit of mycobacterial F-ATP synthase

Subhashri Kundu, Goran Biukovic, Gerhard Grüber, Thomas Dick*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

59 Citations (Scopus)

Abstract

The tuberculosis drug bedaquiline inhibits mycobacterial F-ATP synthase by binding to its c subunit. Using the purified ε subunit of the synthase and spectroscopy, we previously demonstrated that the drug interacts with this protein near its unique tryptophan residue. Here, we show that replacement of ε's tryptophan with alanine resulted in bedaquiline hypersusceptibility of the bacteria. Overexpression of the wild-type ε subunit caused resistance. These results suggest that the drug also targets the ε subunit.

Original languageEnglish
Pages (from-to)6977-6979
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume60
Issue number11
DOIs
Publication statusPublished - Nov 1 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2016 Kundu et al.

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Bedaquiline targets the ε subunit of mycobacterial F-ATP synthase'. Together they form a unique fingerprint.

Cite this